title: Synthesis and antimalarial activity of artemisinin derivatives containing an amino group.
abstract: In search of water-soluble artemisinin derivatives that are more stable than sodium artesunate, over 30 derivatives containing an amino group (compounds 3-5) were synthesized and tested in mice. All products tested (except 5a and 5b) are the beta isomers. These basic compounds combined with organic acids (oxalic acid, maleic acid, etc. ) to yield the corresponding salts. Generally, the maleates have better solubility in water than the corresponding oxalates. The aqueous solutions of these salts can be kept at room temperature for several weeks without any discernible decomposition. Compounds 3f, 3h, and 3r are much more active against P. berghei than artesunic acid by oral administration and therefore were further tested in monkeys. However, their oral efficacies are poorer than that of artesunic acid against P. knowlesi in rhesus monkeys. It is interesting to note that 3f, 3h, and 3r showed much lower efficacies against P. berghei when they were administered subcutaneously than orally.
authors.affiliation: Department of Malaria, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Bejing 100071, China. yli@mail.shcnc..ac.cn
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.forename: Y M
authors.initials: YM
authors.lastname: Zhu
authors.forename: H J
authors.initials: HJ
authors.lastname: Jiang
authors.forename: J P
authors.initials: JP
authors.lastname: Pan
authors.forename: G S
authors.initials: GS
authors.lastname: Wu
authors.forename: J M
authors.initials: JM
authors.lastname: Wu
authors.forename: Y L
authors.initials: YL
authors.lastname: Shi
authors.forename: J D
authors.initials: JD
authors.lastname: Yang
authors.forename: B A
authors.initials: BA
authors.lastname: Wu
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D037621:Artemisinins; D006576:Heterocyclic Compounds, 4 or More Rings / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D007279:Injections, Subcutaneous; D008288:Malaria / Q000188:drug therapy; D051379:Mice; D010962:Plasmodium berghei; D012717:Sesquiterpenes / Q000737:chemistry*; D013329:Structure-Activity Relationship
chemical_list: C407518:1-diethylamino-2-(10-dihydroartemisinoxy)ethane; C407516:1-dimethylamino-2-(10-dihydroartemisinoxy)ethane; C407517:1-morpholino-3-(10-dihydroartemisinoxy)propane; D000962:Antimalarials; D037621:Artemisinins; D006576:Heterocyclic Compounds, 4 or More Rings; D012717:Sesquiterpenes; C031327:artemisinin